PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22055712-4	2011	The results document that the sulfanylcaffeine analogues are reversible competitive MAO-B inhibitors with potencies comparable to those of the oxycaffeines.	sulfanylcaffeine	30-46	monoamine oxidase B	Homo sapiens	84-89	
22055712-6	2011	While the sulfanylcaffeine analogues also exhibit affinities for MAO-A, they display in general a high degree of MAO-B selectivity.	sulfanylcaffeine	10-26	monoamine oxidase B	Homo sapiens	113-118	
22055712-9	2011	MAO-B selective sulfanylcaffeine derived inhibitors may act as lead compounds for the design of antiparkinsonian therapies.	sulfanylcaffeine	16-32	monoamine oxidase B	Homo sapiens	0-5